Canadian biotech industry one of the best in world, but fragile: more than half of our public biotech enterprises face a severe cash crunch: Martin

BY Martin, Paul

November 3, 2003

This is an edited excerpt of Paul Martin's speech he delivered to the Board of Trade of Metropolitan Montreal on Sept. 18.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

FOLLOW THE HILL TIMES:

LICENSING

PODCAST

ALERTS

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

MORE Opinion

Canada’s climate change policies, programs can be more effective if we work with nature in addition to moving away from fossil fuels

opinionBY GREEN PARTY LEADER ELIZABETH MAY, LYNN JONES

Alberta Premier Smith has opened up a Pandora’s box of dangers arising from the referendum question which she may not control

opinionBY ERROL MENDES

The federal government has gone all-in on fossil fuels

opinionBY TIM GRAY

Women need better health care. A national framework can help deliver it

opinionBY MARGOT BURNELL, MARCIA CLARK, SARAH COOK

Now, more than ever, Canada must strengthen co-operation with Mexico to protect rights and sovereignty

opinionBY KATHY PRICE